Page last updated: 2024-10-23

biperiden and Focal Neurologic Deficits

biperiden has been researched along with Focal Neurologic Deficits in 2 studies

Biperiden: A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
biperiden : A member of the class of piperidines that is N-propylpiperidine in which the methyl hydrogens have been replaced by hydroxy, phenyl, and 5-norbornen-2-yl groups. A muscarinic antagonist affecting both the central and peripheral nervous systems, it is used in the treatment of all forms of Parkinson's disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MEDINA, C1
KRAMER, MD1
KURLAND, AA1
ALLEVA, PM1

Other Studies

2 other studies available for biperiden and Focal Neurologic Deficits

ArticleYear
Biperiden in the treatment of phenothiazine-induced extrapyramidal reactions.
    JAMA, 1962, Dec-15, Volume: 182

    Topics: Biperiden; Extrapyramidal Tracts; Humans; Neurologic Manifestations; Parasympathomimetics; Phenothia

1962
[AKINETON IN PARKINSONISM CAUSED BY DRUGS].
    Therapie der Gegenwart, 1963, Volume: 102

    Topics: Anti-Allergic Agents; Biperiden; Haloperidol; Histamine H1 Antagonists; Movement Disorders; Neurolog

1963